Niels Vander Elst
- ORCID iD
-
0000-0001-6289-7288
Show
Sort by
-
- Journal Article
- A1
- open access
Endolysin NC5 improves early cloxacillin treatment in a mouse model of Streptococcus uberis mastitis
-
- Journal Article
- A1
- open access
Development of engineered endolysins with in vitro intracellular activity against streptococcal bovine mastitis‐causing pathogens
-
Engineering of bacteriophage-derived endolysins to treat streptococcal mammary gland infections
(2023) -
Endolysin NC5 improves early cloxacillin treatment in a mouse model for bovine Streptococcus uberis mastitis
-
- Journal Article
- A1
- open access
Priming of the murine mammary gland with Staphylococcus chromogenes IM reduces bacterial growth of Streptococcus uberis : a proof-of-concept study
-
- Conference Paper
- C3
- open access
Characterization of endolysins PlySs2 & -9 with in vitro lytic activity against bovine mastitis Streptococcus uberis
-
A method for the purification of non-pyrogenic bacteriophage derived endolysins with an in vitro or in vivo application
-
- Journal Article
- A1
- open access
One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer
-
One cisplatin dose suffices to maintain anti-tumor immunity and enhances anti-PD-1 efficacy in an intraductal model for triple-negative breast cancer
-
Splenic immunomodulatory effects of cisplatin in an immunocompetent intraductal model for triple-negative breast cancer